HCA Healthcare reported a solid start to QQ1 2025, with revenue of $18.32 billion, up 5.66% year-over-year and 0.20% quarter-over-quarter. Gross profit of $2.855 billion yielded a gross margin of 15.58%, and EBITDA reached $3.734 billion, underscoring the resilience of the core hospital network amid volume-driven demand. Net income totaled $1.61 billion and diluted earnings per share were $6.45, reflecting favorable mix and operating leverage in a capital-intensive services business. Notably, cash generation remained strong, with operating cash flow of $1.651 billion and free cash flow of $660 million, supporting ongoing capital investments and a sizable share repurchase program.